Advertisement

Topics

Garching Innovation GmbH Company Profile

07:12 EST 13th December 2018 | BioPortfolio

GI was founded in 1970. It consists of an interdisciplinary team of scientists, business people, and lawyers. The company's authorized capital stock amounts to EUR 51,129.19 GI concludes agreements in its own name to the account of the MPS. Income from license agreements is transferred to the MPS. The MPS subscribes to the company shares it acquires during licensing negotiations. An advisory board consisting of politicians, scientific experts, and business representatives monitors the work of GI.

Location

Technologien aus derMax-Planck-Gesellschaft
Marstallstraße 8
Munich
80539
Germany

Contact

Phone: 49 / 89 / 29 09 19-0
Fax: 49 / 89 / 29 09 19-99
Email: gi@garching-innovation.de


News Articles [540 Associated News Articles listed on BioPortfolio]

Themis gets oncology-related IP from Max Planck

Max Planck Innovation GMBH licensed Themis Bioscience GMBH exclusive worldwide rights to develop, manufacture, and commercialize cancer therapies based on an oncolytic measles virus platform.

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwid...

Max Planck Innovation GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryMax Planck Innovation GmbH Max Planck, formerly Garching Innovation GmbH, a subsidiary of Max Planck Society is a technology transfer company that offers transferring inventions and technologie...

PubMed Articles [248 Associated PubMed Articles listed on BioPortfolio]

Innovation in the Context of Audiology and in the Context of the Internet.

This article explores different meanings of innovation within the context of audiology and the Internet. Case studies are used to illustrate and elaborate on the new types of innovation and their leve...

The 'full stack' of healthcare innovation skills: combining clinical informatics with care delivery innovation.

Effect of innovation capacity, production capacity and vertical specialization on innovation performance in China's electronic manufacturing: Analysis from the supply and demand sides.

Manufacturing in China has developed rapidly with the widening and deepening of globalization, but only innovation can industry keep upgrading and enhancing its international competitiveness. This pap...

The Barrow Innovation Center case series: Early clinical experience with a novel surgical instrument used to prevent intraoperative spinal cord injuries.

The Barrow Innovation Center comprises an educational program in medical innovation that enables residents to identify problems in patient care and to rapidly develop and implement solutions to these ...

Designing and testing an educational innovation.

Technology provides an opportunity to develop innovations to improve the way we teach. Developing educational innovations must be approached in a methodical and thorough manner to identify the educati...

Clinical Trials [190 Associated Clinical Trials listed on BioPortfolio]

Innovation Adoption in Medical Robotic Surgery: Case of Royal Bournemouth Hospital

This research sets to address two key areas. The first is identified by the researcher in academic literature that there is a lack of a comprehensive innovation adoption model in UK Nation...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Childhood Obesity Prevention Trough Education Innovation in Primary School: A Quasi-experimental Trial

This study evaluates the effect of the education innovation program"chiquichefs" on anthropometric variables, quality of life and nutritional habits in an elementary school children. Compa...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [1491 Associated Companies listed on BioPortfolio]

Garching Innovation GmbH

GI was founded in 1970. It consists of an interdisciplinary team of scientists, business people, and lawyers. The company's authorized capital stock amounts to EUR 51,129.19 GI concludes agreements in...

Max-Planck-Innovation GmbH

Max-Planck-Innovation GmbH is the technology transfer agencyof the Max Planck Society (MPS). Max-Planck-Innovation organizes the transfer of new ideas and inventions to industrial products. Issuing li...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

flyion GmbH

flyion is a spin-off from the Institute of Physiology at the University of Tübingen. The company was founded in February 2001 as a limited liability company (GmbH) in Tübingen, Germany, by Dr. Albre...

Bayer Innovation GmbH

Nil

More Information about "Garching Innovation GmbH" on BioPortfolio

We have published hundreds of Garching Innovation GmbH news stories on BioPortfolio along with dozens of Garching Innovation GmbH Clinical Trials and PubMed Articles about Garching Innovation GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Garching Innovation GmbH Companies in our database. You can also find out about relevant Garching Innovation GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record